BCIQ Profiles

Company Profile Report

Sierra Oncology acquires momelotinib from Gilead

Sierra Oncology Inc. (NASDAQ:SRRA) acquired momelotinib (formerly CYT387) from Gilead Sciences Inc. (NASDAQ:GILD) for $3

Read the full 153 word article

How to gain access

Continue reading with a
two-week free trial.